The use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant

Details for Australian Patent Application No. 2005244079 (hide)

Owner Pulmonox Technologies Corporation

Inventors Perry, Bryan; Miller, Christopher; Murray, Bruce; Hole, Doug

Agent Spruson & Ferguson

Pub. Number AU-A-2005244079

PCT Pub. Number WO2005/110052

Priority 60/569,888 11.05.04 US

Filing date 11 May 2005

Wipo publication date 24 November 2005

International Classifications

A61M 11/00 (2006.01) Sprayers

A61M 15/00 (2006.01) Inhaling devices

A61M 15/08 (2006.01) Inhaling devices - Inhaling devices inserted into the nose

A61M 16/00 (2006.01) Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration

A62B 7/00 (2006.01) Respirators

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/110052 Priority application(s): WO2005/110052

4 June 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244081-T-cell death-inducing epitopes

2005244078-Intermittent dosing of nitric oxide gas